Literature DB >> 23245857

The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis.

Borna Müller1, Sonia Borrell, Graham Rose, Sebastien Gagneux.   

Abstract

Recent surveillance data of multidrug-resistant tuberculosis (MDR-TB) reported the highest rates of resistance ever documented. As further amplification of resistance in MDR strains of Mycobacterium tuberculosis occurs, extensively drug-resistant (XDR) and totally drug-resistant (TDR) TB are beginning to emerge. Although for the most part, the epidemiological factors involved in the spread of MDR-TB are understood, insights into the bacterial drivers of MDR-TB have been gained only recently, largely owing to novel technologies and research in other organisms. Herein, we review recent findings on how bacterial factors, such as persistence, hypermutation, the complex interrelation between drug resistance and fitness, compensatory evolution, and epistasis affect the evolution of multidrug resistance in M. tuberculosis. Improved knowledge of these factors will help better predict the future trajectory of MDR-TB, and contribute to the development of new tools and strategies to combat this growing public health threat.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23245857      PMCID: PMC3594559          DOI: 10.1016/j.tig.2012.11.005

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  89 in total

1.  Fitness cost of chromosomal drug resistance-conferring mutations.

Authors:  Peter Sander; Burkhard Springer; Therdsak Prammananan; Antje Sturmfels; Martin Kappler; Michel Pletschette; Erik C Böttger
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux.

Authors:  Gail E Louw; Robin M Warren; Nicolaas C Gey van Pittius; Rosalba Leon; Adelina Jimenez; Rogelio Hernandez-Pando; Christopher R E McEvoy; Melanie Grobbelaar; Megan Murray; Paul D van Helden; Thomas C Victor
Journal:  Am J Respir Crit Care Med       Date:  2011-04-21       Impact factor: 21.405

3.  Tubercle bacilli resistant to isoniazid: virulence and response to treatment with isoniazid in guinea-pigs and mice.

Authors:  M BARNETT; S R BUSBY; D A MITCHISON
Journal:  Br J Exp Pathol       Date:  1953-10

4.  Bacterial persistence as a phenotypic switch.

Authors:  Nathalie Q Balaban; Jack Merrin; Remy Chait; Lukasz Kowalik; Stanislas Leibler
Journal:  Science       Date:  2004-08-12       Impact factor: 47.728

5.  Fitness of antibiotic-resistant microorganisms and compensatory mutations.

Authors:  E C Böttger; B Springer; M Pletschette; P Sander
Journal:  Nat Med       Date:  1998-12       Impact factor: 53.440

6.  The population genetics of antibiotic resistance.

Authors:  B R Levin; M Lipsitch; V Perrot; S Schrag; R Antia; L Simonsen; N M Walker; F M Stewart
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

7.  The competitive cost of antibiotic resistance in Mycobacterium tuberculosis.

Authors:  Sebastien Gagneux; Clara Davis Long; Peter M Small; Tran Van; Gary K Schoolnik; Brendan J M Bohannan
Journal:  Science       Date:  2006-06-30       Impact factor: 47.728

Review 8.  Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis.

Authors:  Christopher Dye; Brian G Williams; Marcos A Espinal; Mario C Raviglione
Journal:  Science       Date:  2002-03-15       Impact factor: 47.728

9.  Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience in The Netherlands.

Authors:  H R van Doorn; P E W de Haas; K Kremer; C M J E Vandenbroucke-Grauls; M W Borgdorff; D van Soolingen
Journal:  Clin Microbiol Infect       Date:  2006-08       Impact factor: 8.067

Review 10.  Mycobacterial subversion of chemotherapeutic reagents and host defense tactics: challenges in tuberculosis drug development.

Authors:  Liem Nguyen; Jean Pieters
Journal:  Annu Rev Pharmacol Toxicol       Date:  2009       Impact factor: 13.820

View more
  78 in total

1.  Translating the Tuberculosis Research Agenda: Much Accomplished, but Much More to Be Done.

Authors:  Marco Schito; Markus Maeurer; Peter Kim; Debra Hanna; Alimuddin Zumla
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

2.  Correlation of Single Nucleotide Polymorphism 35-Kb Upstream of HLA-C and Clinical Profile of Multidrug-Resistant Tuberculosis.

Authors:  Umi Hani' Vismayanti Lismana; Afiono Agung Prasetyo
Journal:  J Clin Diagn Res       Date:  2015-09-01

3.  Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance.

Authors:  Hongtai Zhang; Dongfang Li; Lili Zhao; Joy Fleming; Nan Lin; Ting Wang; Zhangyi Liu; Chuanyou Li; Nicholas Galwey; Jiaoyu Deng; Ying Zhou; Yuanfang Zhu; Yunrong Gao; Tong Wang; Shihua Wang; Yufen Huang; Ming Wang; Qiu Zhong; Lin Zhou; Tao Chen; Jie Zhou; Ruifu Yang; Guofeng Zhu; Haiying Hang; Jia Zhang; Fabin Li; Kanglin Wan; Jun Wang; Xian-En Zhang; Lijun Bi
Journal:  Nat Genet       Date:  2013-09-01       Impact factor: 38.330

4.  Compensatory Mutations of Rifampin Resistance Are Associated with Transmission of Multidrug-Resistant Mycobacterium tuberculosis Beijing Genotype Strains in China.

Authors:  Qin-Jing Li; Wei-Wei Jiao; Qing-Qin Yin; Fang Xu; Jie-Qiong Li; Lin Sun; Jing Xiao; Ying-Jia Li; Igor Mokrousov; Hai-Rong Huang; A-Dong Shen
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

5.  Whole genome sequence analysis of multidrug-resistant Mycobacterium tuberculosis Beijing isolates from an outbreak in Thailand.

Authors:  Sanjib Mani Regmi; Angkana Chaiprasert; Supasak Kulawonganunchai; Sissades Tongsima; Olabisi Oluwabukola Coker; Therdsak Prammananan; Wasna Viratyosin; Iyarit Thaipisuttikul
Journal:  Mol Genet Genomics       Date:  2015-04-24       Impact factor: 3.291

6.  Real-Time Sequencing of Mycobacterium tuberculosis: Are We There Yet?

Authors:  Robyn S Lee; Madhukar Pai
Journal:  J Clin Microbiol       Date:  2017-03-15       Impact factor: 5.948

Review 7.  Clinical implication of novel drug resistance-conferring mutations in resistant tuberculosis.

Authors:  N P Mnyambwa; D-J Kim; E S Ngadaya; R Kazwala; P Petrucka; S G Mfinanga
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-06-07       Impact factor: 3.267

8.  First Insight Into the Fluoroquinolone and Aminoglycoside Resistance of Multidrug-Resistant Mycobacterium tuberculosis in Saudi Arabia.

Authors:  Bright Varghese; Sahal Al-Hajoj
Journal:  Am J Trop Med Hyg       Date:  2017-05       Impact factor: 2.345

Review 9.  Mobile genetic elements of the human gastrointestinal tract: potential for spread of antibiotic resistance genes.

Authors:  Eileen Broaders; Cormac G M Gahan; Julian R Marchesi
Journal:  Gut Microbes       Date:  2013-04-12

Review 10.  Diversity and evolution of Mycobacterium tuberculosis: moving to whole-genome-based approaches.

Authors:  Stefan Niemann; Philip Supply
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-04       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.